Cargando…
Ghrelin Protects Against Insulin-Induced Hypoglycemia in a Mouse Model of Type 1 Diabetes Mellitus
Insulin-induced hypoglycemia is a major limiting factor in maintaining optimal blood glucose in patients with type 1 diabetes and advanced type 2 diabetes. Luckily, a counterregulatory response (1) system exists to help minimize and reverse hypoglycemia, although more studies are needed to better ch...
Autores principales: | Shankar, Kripa, Gupta, Deepali, Mani, Bharath K., Findley, Brianna G., Osborne-Lawrence, Sherri, Metzger, Nathan P., Liu, Chen, Berglund, Eric D., Zigman, Jeffrey M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7518392/ https://www.ncbi.nlm.nih.gov/pubmed/33042003 http://dx.doi.org/10.3389/fendo.2020.00606 |
Ejemplares similares
-
Ghrelin does not impact the blunted counterregulatory response to recurrent hypoglycemia in mice
por: Shankar, Kripa, et al.
Publicado: (2023) -
Ghrelin cell–expressed insulin receptors mediate meal- and obesity-induced declines in plasma ghrelin
por: Shankar, Kripa, et al.
Publicado: (2021) -
OR12-04 LEAP2 Deletion Does Not Counteract The Effects Of Ghrelin Deletion During Insulin-Induced-Hypoglycemia
por: Shankar, Kripa, et al.
Publicado: (2023) -
Role of Growth Hormone in Ghrelin’s Metabolic Actions
por: Gupta, Deepali, et al.
Publicado: (2021) -
THU309 Ghrelin Deficiency Does Not Improve Glucose Tolerance And Insulin Secretion In Female Mice
por: Gupta, Deepali, et al.
Publicado: (2023)